ABSTRACT. Activity of nonmuscle myosin II is regulated by phosphorylation of its regulatory light chain (MRLC). Phosphoryration of MRLC at both Thr18 and Ser19 (diphosphorylation) results in higher MgATPase activity and in promotion of the assembly of myosin II filaments than does that of MRLC at Ser19 (monophosphorylation) in vitro. To determine the roles of the diphosphorylated MRLC in vivo, we transfected three kinds of MRLC mutants, unphosphorylated, monophosphorylated and diphosphorylated forms (MRLC2 T18AS19A , substitution of both Ser19 and Thr18 by Ala; MRLC2 T18AS19D , Ser19 by Asp and Thr18 by Ala; and MRLC2 T18DS19D , both Ser19 and Thr18 by Asp, respectively), into HeLa cells. Cells overexpressing the mutant MRLC2 T18DS19D contained a larger number of actin filament bundles than did those overexpressing the mutant MRLC2 T18AS19D . Moreover, cells overexpressing the nonphosphorylatable mutant MRLC2 T18AS19A showed a decrease in the number of actin filament bundles. Taken together, our data suggest that diphosphorylation of MRLC plays an important role in regulating actin filament assembly and reorganization in nonmuscle cells.
Myosin II is an essential protein to generate force for cell locomotion (Berlot et al., 1985 (Berlot et al., , 1987 and cytokinesis (Mabuchi and Okuno, 1977; De Lozanne and Spudich, 1987) . In smooth muscle and vertebrate nonmuscle cells, myosin II activity is both negatively and positively regulated by phosphorylation of its regulatory light chain (MRLC). The phosphorylation sites of MRLC by Ca 2+ /calmodulindependent myosin light chain kinase (MLCK) are mainly Ser19 (monophosphorylation) and, under some conditions, both Ser19 and Thr18 (diphosphorylation) in vitro (Ikebe and Hartshorne, 1985; Ikebe et al., 1986) . Phosphorylation of MRLC by MLCK enhances the actin activated Mg ATPase activity (Sellers et al., 1981; Trybus, 1989) and promotes the assembly of myosin II filaments (Suzuki et al., 1978) . These effects are more effective when MRLC is diphosphorylated (Ikebe et al., 1988) . On the other hand, protein kinase C (PKC) phosphorylates MRLC at Ser1/2 and Thr9. Phosphorylation of MRLC by PKC down-regulate the MgATPase activity of myosin II phosphorylated by MLCK (Nishikawa et al., 1984; Ikebe et al., 1987) .
It has been reported that substitution of amino acid residues on phosphorylation sites of MRLC affects the biochemical properties of myosin II in vitro. Substitution of both Ser19 and Thr18 to Asp, which mimics the diphosphorylated MRLC, exerted the actin activated MgATPase activity of myosin II and formation of myosin II filaments (Kamisoyama et al., 1994; Sweeney et al., 1994) .
In this study, we attempted to determine the roles of diphosphorylated MRLC in vivo. To address this, we transfected three kinds of MRLC mutants, which mimic nonphosphorylated, monophosphorylated and diphosphorylated MRLC, into HeLa cells and compared their localization in both interphase and mitotic cells.
Materials and Methods

Materials
MLCK was purified from chicken gizzard (Adelstein and Klee, 1981) . Calmodulin from bovine brain, calyculin A, phenylmethylsulfonyl fluoride (PMSF), bovine serum albumin (BSA) and coumarin phenylisothiocyanate (CPITC)-conjugated phalloidin were purchased from Sigma Chemical (St. Louis, MO, USA), leupeptin and pepstatin A from the Peptide Institute (Osaka, Japan) and the mouse anti-myc monoclonal antibody from Invitrogen (Groningen, The Netherlands). The rabbit anti-myosin II heavy chain polyclonal antibody (Fujiwara and Pollard, 1976) was kindly provided by Drs K. Fujiwara (University of Rochester, NY, USA) and K. Katoh (National Cardiovascular Center Reserch Institute, Tokyo, Japan) . Fluorescein isothiocyanate (FITC) conjugated anti-mouse IgG (Fc) was purchased from TAGO Inc. (Burlingame, CA, USA). Rhodamine-conjugated phalloidin, Alexa Fluor 488 conjugated goat anti-mouse IgG and Alexa Fluor 568 conjugated goat antirabbit IgG were from Molecular Probes (Eugene, OR, USA). HeLa cells (RCB0007; just like ATCC CCL2, HeLa) were obtained from the Riken Cell Bank (Tsukuba, Japan) and cultured as described previously (Murata-Hori et al., 2000) . Rat embryo fibroblast (REF) cells (RCB0165) were also obtained from the Riken Cell Bank, and cultured in Dulbecco's Modified Eagle's Medium (Nissui Pharmaceutical, Tokyo, Japan) supplemented with 10% fetal calf serum in 10 cm plastic culture dishes (Sumitomo Bakelite, Tokyo, Japan).
Screening of HeLa MRLC cDNAs
Three kinds of MRLC cDNAs (termed as HeLa MRLC1, HeLa MRLC2 and HeLa MRLC3, respectively) were amplified from the HeLa cell cDNA library (Murata-Hori et al., 1999 ) using a primer set encoding a partial sequence of chicken MRLC (MFLTMF-GEK; amino acid 84-92), and then subcloned into pBluescript SK(-). Screening of HeLa cDNA library using the obtained cDNA fragments was performed as described previously (Murata-Hori et al., 1999) . Sequencing of the cloned cDNA was done with a DNA sequencer (ALF Express II; Amersham Pharmacia Biotech, Uppsala, Sweden). Sequences were analyzed with the software DNA-SIS (Hitachi Software Engineering, Kanagawa, Japan).
Construction of recombinant MRLC expressing vectors
Three types of mutant HeLa MRLC2 (termed as MRLC2 T18AS19A , MRLC2 T18AS19D and MRLC2 T18DS19D , respectively) and wild type MRLC2 were generated by site-directed mutagenesis using PCR. In the MRLC2 T18AS19A mutant, both Ser19 and Thr18 were substituted by Ala. In the MRLC2 T18AS19D mutant, Ser19 was substituted by Asp and Thr18 by Ala, respectively. In the MRLC2 T18DS19D mutant, both Ser19 and Thr18 were substituted by Asp. PCR products were subcloned into pGEM-T vector (Promega, Madison, WI, USA) and sequenced. Wild type and three mutant MRLC2s were inserted into the frame with the C-terminal myc peptide of pcDNA3.1/Myc-HisA vector (Invitrogen).
Expression of recombinant MRLC2 in HeLa cells
HeLa cells were plated at a density of 10 4 cells per 3.5 cm dish for immunoblotting and immunofluorescence, and at a density of 10 5 cells per 10 cm dish for immunoprecipitation. The cells were incubated with the LipofectAMINE (Gibco BRL, Rockville, MD, USA)-DNA complex at 37°C for 5 h in OPTI-MEM I Reduced Serum Medium (Gibco BRL). After removing the medium, Minimum Essential Medium (Nissui Pharmaceutical) containing 10% fetal bovine serum (Intergen, NY, USA) was added and the cells were cultured for an additional 24 h at 37°C.
Immunoprecipitation and immunoblot analysis
The transfected cells were washed with PBS containing 0.2 mM EGTA, 5 mM MgCl2 and 1 mM PMSF, and then lysed with ice cold RIPA buffer (50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 10 mM EGTA, 1% Nonidet P-40, 0.5% sodium deoxycholate and 0.1% SDS) containing protease inhibitors (10 mM leupeptin, 1 mM pepstain A and 1 mM PMSF). The cell lysates were preincubated with protein G-Sepharose beads (Amersham Pharmacia Biotech) for 1 h at 4°C. After centrifugation, the cell lysates were incubated with 3 mg of anti-myc antibody or mouse IgG for 1 h at 4°C. Protein G-Sepharose beads were added into the cell lysates and incubated for 1 h at 4°C. The beads were washed three times with ice cold RIPA buffer and then washed with PBS. Immunoblotting was performed according to Murata-Hori et al. (1998) .
Protein kinase assay
Phosphorylation of immunoprecipitants by MLCK was carried out in 20 ml of the kinase mixture containing 25 mM Tris-HCl (pH 7.2), 125 mM NaCl, 8 mM MgCl2, 1.3 mM CaCl2, 1.2 mM EGTA, 1.7 mM DTT, 0.1 mM PMSF, 0.5 mM calyculin A, 0.9 mM [g-32 P] ATP (0.1 mCi/ml) and 50 mg/ml calmodulin. MLCK was added at a final concentration of 1 or 100 mg/ml, and incubated for 30 min or 90 min at 25°C, respectively. After incubation, the reaction was stopped by the addition of 5 ml of 5×SDS sample buffer (Okubo et al., 1999) . The samples were separated by SDS-PAGE. Radiolabeled bands were visualized with an imaging analyzer (Bas 2000; Fuji Photo Film, Tokyo, Japan).
Indirect immunofluorescence staining
Indirect immunofluorescence was carried out by the method of Murata-Hori et al. (2001) . Imaging was performed under a Nikon ECLIPSE TE300 microscope. All images were obtained with a digital CCD camera (ORCA, C4742-95-12; Hamamatsu Photonics, Shizuoka, Japan) and processed with a custom software.
Results and Discussion
We first isolated three isoforms of MRLC cDNAs (termed as HeLa MRLC1, HeLa MRLC2 and HeLa MRLC3, respectively) from the HeLa cell cDNA library (Fig. 1) . All MRLCs were highly homologous with each other, and showed more than 90% amino acid identity to that from chicken smooth muscle (Pearson et al., 1984) . Moreover, the phosphorylation sites of MRLC by MLCK were well conserved among these three MRLC isoforms (Fig. 1,  underlined portions) . This result suggests that nonmuscle MRLC regulates myosin II activity in the same manner as that of smooth muscle myosin II (Umemoto et al., 1989) .
In cultured mammalian cells, monophosphorylated MRLC was localized on stress fibers or cell periphery of interphase cells (Matsumura et al., 1998) and along the contractile ring in dividing cells (Matsumura et al., 1998; Murata-Hori et al., 1998) . Recently, we showed that the diphoshorylated MRLC was colocalized with actin stress fibers in interphase rat embryo fibroblast (REF) cells (Murata-Hori et al., 2001) . To determine the localization of the diphosphorylated MRLC in dividing cells, we doubly stained REF cells with rhodamine-phalloidin and the antibody PP1, which specifically recognizes the diphosphorylated but not the non-or monophosphorylated MRLC (Murata-Hori et al., 2001) . The diphosphorylated MRLC was well colocalized along the contractile ring as well as actin stress fibers in interphase cells (Fig. 2) . These results indicate that the diphosphorylated MRLC is colocalized with actin filaments in mitotic cells as well as interphase cells, as described previously (Murata-Hori et al., 2001) .
To elucidate whether the diphosphorylation of MRLC is involved in actin filament assembly in both interphase and mitotic cells, we constructed three recombinants of HeLa MRLC2 using pcDNA3.1/Myc-HisA vector as shown in Fig. 3A . The first mutant of MRLC, MRLC2 T18AS19A (substitution of Thr18 and Ser19 by Ala), mimics the unphosphorylated MRLC. The second one, MRLC2 T18AS19D (substitution of Thr18 with Ala and Ser19 with Asp), minics the monophosphorylated form of MRLC. The third one mimics the diphosphorylated form of MRLC (MRLC2 T18DS19D ), by substituting both Thr18 and Ser19 with Asp.
Each recombinant MRLC2 was transfected into HeLa cells and subjected to immunoprecipitation with anti-myc antibody. Fig. 3B showed that the reacted band corresponding to the recombinant MRLC2 was obtained in each immunoprecipitant (lower panel; lanes 1, 3, 5 and 7). A 200-kDa myosin II heavy chain was also co-immunoprecipitated with all MRLC2 mutants by anti-myc antibody (Fig. 3B,  upper panel) . This result indicates that each of recombinant MRLC2 could be incorporated into myosin II molecules in vivo. Immunoprecipitated MRLC2 mutants were subjected to in vitro kinase assay (Fig. 3C) . The immunoprecipitants were incubated with [g-32 P] ATP and 1 mg/ml or 100 mg/ml MLCK for monophpsphorylation or diphosphorylation of MRLC, respectively. Phosphorylation of the recombinant MRLC2s was detected by autoradiography. Expressed wild type MRLC2 was phosphotylated by MLCK (Fig. 3C, WT) , whereas other recombinants were not phosphorylated by any concentrations of MLCK (Fig. 3C , AA, AD and DD). These findings suggest that each recombinant MRLC2 has the ability to mimic endogenous nonphosphorylated, monophosphorylated and diphosphorylated MRLC in the cells, respectively. When the unphosphorylated form of MRLC, MRLC2 T18AS19A , was transfected into HeLa cells, most of the MRLC2 T18AS19A became diffusely distributed in the cytoplasm (Fig. 4A, d) . In most MRLC2 T18AS19D -expressing cells, the monophosphorylated form of MRLC colocalized with actin filaments containing myosin II heavy chain ( . Recombinant MRLC2s were immunoprecipitated with anti-myc antibody and incubated with absence (left) or 1 mg/ml (center) or 100 mg/ml (right) of MLCK. Recombinant MRLC2s were then subjected to SDS-PAGE followed by autoradiography. WT, AA, AD and DD indicate wild type MRLC2, MRLC2 T18AS19A , MRLC2 T18AS19D and MRLC2 T18DS19D , respectively. 4A, g-i), as in wild type MRLC2 transfected cells (Fig. 4A,  a-c) . In the majority of MRLC2 T18DS19D -expressing cells, many thick fibers containing the diphosphorylated form of MRLC were observed throughout the cytoplasm (Fig. 4A,  j) . They were heavily stained with both anti-myosin II heavy chain antibody and CPITC-phalloidin in the cell (Fig.  4A, k and l) , suggesting that diphosphorylation of MRLC induces the formation of thick actin bundles containing myosin II. Interestingly, in MRLC2 T18AS19A -expressing cells, less obvious thick fibers stained with both anti-myosin II heavy chain antibody and CPITC-phalloidin were observed throughout the cytoplasm. This suggests that the unphosphorylated form of MRLC dominant-negatively inhibits formation of actin bundles in the cytoplasm. Based on the localization of each mutant in the cell, we classified the transfected cells into three types (Fig. 4B) . Fig. 4B revealed that MRLC2 T18DS19D can promote bundling of actin filaments much more effectively than does MRLC2 T18AS19D or MRLC2 T18AS19A in interphase HeLa cells, suggesting that diphosphorylated MRLC can promote actin bundle organization much more effectively than does mono-or unphosphorylated MRLC in interphase HeLa cells. Recently, we firstly reported the in vivo diphosphorylation of MRLC by ZIP kinase in HeLa cells (Murata-Hori et al., 2001) . In this experiments, the diphosphorylated but not the monophosphorylated MRLC was localized prominently on aggregates of actin filaments induced by overexpression of ZIP kinase (Murata-Hori et al., 2001) . This strongly supports the results observed here.
In dividing HeLa cells, both MRLC2 T18AS19D and MRLC2 T18DS19D were also well colocalized with the actin filaments in the peripheral region (arrowheads) and the contractile ring (arrows) (Fig. 5c-f ), while MRLC2 T18AS19A was localized diffusely throughout the cytoplasm in dividing cells (Fig. 5b) as well as in interphase cells (see Fig. 4A , df). It has been reported that both the monophosphorylated (Murata-Hori et al., 1998; Matsumura et al., 1998) and the diphosphorylated MRLC (Fig. 2) localized on the contractile ring. In this study, we could not find any obvious difference of myosin II localization on the actin bundles along the contractile ring between the cells transfected with MRLC2 T18AS19D (n=3) and MRLC2 T18DS19D (n=6). Taken together, these results indicate that phosphorylation of MRLC is essential for myosin II to localize at the contractile ring, suggesting that it is required for the contraction of the contractile ring.
In interphase cells, myosin II containing the diphosphorylated form of MRLC localized more densely along actin filaments and/or stress fibers rather than did that containing the monophosphorylated form of MRLC. This suggests that the diphosphorylated myosin II plays more important roles, such as maintenance of stress fibers and regulation of cytoplasmic tension (Katoh et al., 2001) , than did the monophosphorylated myosin II.
In conclusion, the diphosphorylated form of MRLC, as well as monophosphorylated form of MRLC, is required for the organization of stress fibers in interphase cells and the contractile ring in dividing cells. Moreover, the diphosphorylated MRLC might be more effective in the organization of actin filaments than the monophosphorylated MRLC in interphase cells. were also well colocalized with the actin filaments in the peripheralregion (arrowheads) and the contractile ring (arrows). Bar, 10mm.
